Mayne Pharma Group Limited
MAYNF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $60 | $54 | $110 | $109 |
| Short-Term Investments | $41 | $71 | $39 | $46 |
| Receivables | $165 | $176 | $193 | $171 |
| Inventory | $51 | $61 | $75 | $92 |
| Other Curr. Assets | $37 | $68 | $43 | $57 |
| Total Curr. Assets | $353 | $429 | $461 | $475 |
| Property Plant & Equip (Net) | $59 | $57 | $53 | $50 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $542 | $576 | $569 | $583 |
| Long-Term Investments | $0 | $0 | $15 | $0 |
| Tax Assets | $0 | $0 | $45 | $28 |
| Other NC Assets | $61 | $68 | $0 | $17 |
| Total NC Assets | $662 | $701 | $683 | $678 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,015 | $1,131 | $1,143 | $1,154 |
| Liabilities | – | – | – | – |
| Payables | $30 | $27 | $21 | $43 |
| Short-Term Debt | $39 | $37 | $35 | -$4 |
| Tax Payable | $0 | $0 | $0 | $1 |
| Deferred Revenue | $0 | $0 | $7 | $7 |
| Other Curr. Liab. | $192 | $242 | $251 | $248 |
| Total Curr. Liab. | $261 | $306 | $314 | $296 |
| LT Debt | $3 | $3 | $35 | $33 |
| Deferred Rev, NC | $0 | $0 | $0 | $6 |
| Deferred Tax Liab, NC | $0 | $0 | $7 | $7 |
| Other NC Liab. | $381 | $376 | $333 | $264 |
| Total NC Liab. | $383 | $379 | $375 | $310 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $6 | $7 | $7 | $7 |
| Total Liabilities | $644 | $685 | $689 | $606 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1,226 | $1,226 | $1,224 | $1,224 |
| Retained Earnings | -$1,041 | -$970 | -$944 | -$840 |
| AOCI | $185 | $190 | $174 | $164 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $370 | $446 | $454 | $548 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,015 | $1,131 | $1,143 | $1,154 |
| Net Debt | -$19 | -$14 | -$40 | -$80 |